Source: Health Products and Food Branch (CA) Revision Year: 2023
LIBRAX – Chlordiazepoxide Hydrochloride, 5mg / Clidinium Bromide, 2.5mg
Capsules, Oral – Anxiolytic-Anticholinergic Agent.
Table 1. Dosage Forms, Strengths, Composition and Packaging:
| Route of Administration | Dosage Form / Strength/Composition | Non-medicinal Ingredients |
|---|---|---|
| Oral | Capsule chlordiazepoxide hydrochloride, 5mg clidinium bromide, 2.5mg | Gelatin, lactose monohydrate, starch, talc, titanium dioxide, D&C Yellow #10, FD&C Green, black imprinting ink. |
Each green #4 capsule imprinted with LIBRAX contains 5 mg chlordiazepoxide hydrochloride and 2.5 mg clidinium bromide. Available in bottles of 100 capsules.
| Marketing Informations | Authorization Dates |
|---|---|
|
Authorization holder:
Bausch Health, Canada Inc, 2150 St-Elzear Blvd. West, Laval, Quebec, H7L 4A8 253166 |
Date of approval:
Dec 31, 1961 December 14, 2021 |
| Drug | Countries | |
|---|---|---|
| LIBRAX | Canada, Cyprus, Finland, France, Tunisia, Turkey, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
